Cardiotoxicity
| Cardiotoxicity | |
|---|---|
| [[File:|250px|]] | |
| Synonyms | |
| Pronounce | |
| Specialty | Cardiology, Oncology |
| Symptoms | |
| Complications | |
| Onset | |
| Duration | |
| Types | |
| Causes | Exposure to cardiotoxic agents |
| Risks | |
| Diagnosis | Echocardiogram, Electrocardiogram, Blood tests |
| Differential diagnosis | |
| Prevention | |
| Treatment | |
| Medication | |
| Prognosis | |
| Frequency | |
| Deaths | |
Cardiotoxicity refers to damage to the heart by harmful chemicals. As a significant side effect of certain medications, particularly chemotherapy agents and other drugs, it poses a serious risk for patients undergoing treatment for various conditions, including cancer. The understanding and management of cardiotoxicity are crucial in the fields of cardiology and oncology.
Causes[edit | edit source]
Cardiotoxicity can be caused by numerous agents including:
- Chemotherapy drugs, such as anthracyclines (e.g., doxorubicin), and monoclonal antibodies (e.g., trastuzumab)
- Radiation therapy, especially when the heart is within the radiation field
- Some targeted therapies and other medications, such as tyrosine kinase inhibitors
- Excessive exposure to certain environmental toxins
Mechanisms[edit | edit source]
The mechanisms of cardiotoxicity vary depending on the causative agent. For example, anthracyclines induce cardiotoxicity primarily through the generation of free radicals, which damage the cardiac muscle. Trastuzumab, on the other hand, can lead to heart dysfunction by interfering with HER2 signals, which are important for heart cell survival and repair.
Symptoms[edit | edit source]
Symptoms of cardiotoxicity may include:
Diagnosis[edit | edit source]
Diagnosis of cardiotoxicity generally involves:
- Echocardiogram to assess heart function
- Electrocardiogram (ECG) to monitor heart rhythm
- Blood tests to measure cardiac biomarkers
Prevention and Management[edit | edit source]
Prevention and management strategies for cardiotoxicity include:
- Regular monitoring of heart function during and after treatment
- Use of cardioprotective agents
- Dose modification or discontinuation of the cardiotoxic drug
Prognosis[edit | edit source]
The prognosis for patients with cardiotoxicity varies based on the severity of the damage and the response to management strategies. Early detection and intervention are critical for improving outcomes.
See also[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
